European Archives - Page 52 of 1556 - European Medical Journal

Acoustic Analysis Shows Promise for Cognitive Impairment Screening

Acoustic Analysis Shows Promise for Cognitive Impairment Screening

Evidence suggests acoustic analysis of routine patient-clinician conversations may be able to accurately identify cognitive impairment.

Fecal Calprotectin Predicts Gastrointestinal GVHD After Transplant

Fecal Calprotectin Predicts Gastrointestinal GVHD After Transplant

A prospective study found fecal calprotectin could help predict, diagnose, and monitor gastrointestinal graft versus host disease after allogeneic stem cell transplantation.

Hair Product Allergens Linked to Microbiome Changes in Scalp Dermatitis

Hair Product Allergens Tied to Microbiome Changes in Scalp Dermatitis

A study reveals links between hair care allergen sensitisation, skin barrier dysfunction, and microbiome changes in scalp seborrheic dermatitis.

40% of Midwives Worldwide Intend to Leave Profession

40% of Midwives Worldwide Intend to Leave Profession

Around two out of every five midwives worldwide intend to leave the profession, a new first-of-its-kind study has found.

Gut Microbiome Aids DVT Classification Using AI – EMJ

Machine Learning Links Gut Microbiome to Improved DVT Detection

New machine learning model demonstrates how deep vein thrombosis may be identified more accurately using gut microbiome profiles.

Aortic Stiffness Predicts Risk in Autoimmune Rheumatic Diseases - EMJ

Artery Stiffness Test Beats SCORE2 in Autoimmune Rheumatic Diseases

New research shows carotid-femoral pulse wave velocity outperforms the SCORE2 algorithm for predicting cardiovascular events in rheumatic diseases.

Acne Scar Treatments Compared: Laser vs Microneedling - EMJ

Acne Scar Treatment: CO₂ Laser Compared with Microneedling

A systematic review compares fractional CO₂ laser and needling treatments for acne scars, assessing effectiveness, safety, and treatment-related risks.

Automated CT Analysis May Improve Neurological Recovery

EARLY assessment of neurological recovery following cardiac arrest could be improved through automated analysis of brain imaging

FGFR2 Targeted Therapy Shows Promise in Gastric Cancer - EMJ

FGFR2 Amplified Gastric Cancer Responds to Infigratinib

Phase 2 data show infigratinib achieved a 23.8% objective response rate in FGFR2 amplified gastric cancer, supporting further evaluation of targeted treatment strategies.

MVX Score Improves MASLD Risk Prediction - EMJ

MVX Score Predicts Mortality Risk in MASLD

The MVX score may help identify patients with MASLD who are at greatest risk of death and liver-related complications.